![](/assets/images/down.png)
![](/assets/images/up.png)
Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-08-01 | 2024-06 | -3.47 | -3.33 | 0.14 | 4.03% |
2024-05-02 | 2024-03 | -3.59 | -3.07 | 0.52 | 14.48% |
2024-05-02 | 2024-03 | -3.59 | N/A | N/A | N/A |
2024-02-22 | 2023-12 | -0.78 | 0.55 | 1.33 | 170.51% |
2024-02-22 | 2023-12 | -0.78 | N/A | N/A | N/A |
2023-11-02 | 2023-09 | -2.01 | N/A | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-09-12 | Argus Research | Upgrade | Buy | Buy |
2023-08-03 | TD Cowen | Downgrade | Outperform | Market Perform |
2023-08-03 | RBC Capital | Upgrade | Outperform | Outperform |
2023-08-03 | B of A Securities | Upgrade | Neutral | Neutral |
2023-08-03 | Morgan Stanley | Upgrade | Equal-Weight | Equal-Weight |
2023-08-02 | Deutsche Bank | Downgrade | Buy | Hold |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-07-30 | AFEYAN NOUBAR BOGHOS | Director | 6.86M | Sale |
2022-12-27 | ANDRES JUAN | Chief Technology Officer | 12.80K | Sale |
2024-02-15 | BANCEL STEPHANE J | Chief Executive Officer | 21.08M | Sale |
2024-05-02 | BERENSON STEPHEN A. | Director | 22.20K | Conversion of Exercise of derivative security |
2023-12-05 | GARAY ARPA | Officer | 3.69K | Sale |
2024-09-02 | HOGE STEPHEN | President | 1.60M | Sale |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Baillie Gifford and Company | 45.71M | 5.55B | 12.01% |
2023-06-29 | Vanguard Group Inc | 27.46M | 3.34B | 7.22% |
2023-06-29 | Blackrock Inc. | 24.16M | 2.94B | 6.35% |
2023-06-29 | State Street Corporation | 14.23M | 1.73B | 3.74% |
2023-06-29 | Flagship Pioneering Inc. | 12.89M | 1.57B | 3.39% |
2023-06-29 | Coatue Management LLC | 6.55M | 795.35M | 1.72% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 10.11M | 1.23B | 2.66% |
2023-05-30 | Vanguard International Growth Fund | 9.42M | 1.20B | 2.47% |
2023-06-29 | Vanguard 500 Index Fund | 7.81M | 948.38M | 2.05% |
2023-08-30 | Invesco ETF Tr-Invesco QQQ Tr, Series 1 ETF | 6.46M | 730.48M | 1.70% |
2023-07-30 | Vanguard Specialized-Health Care Fund | 4.45M | 523.90M | 1.17% |
2023-05-30 | Fidelity 500 Index Fund | 3.70M | 472.16M | 0.97% |
Split | Date |
---|---|
1 : 10 | 2017-08-03 |
-
MRNA is accepting new patients for phase 2
-
-
The fun is over..
-
Focus of phase 1 is safety not anything else. The outcome was so good that they also talked about antibodies during press conference but they didn’t need to do that. Watch this interview. This is going to be blockbuster.
https://www.cnn.com/2020/05/18/health/coronavirus-vaccine-moderna-early-results/index.html
-
-
$MRNA last 10 mins it will go down like crazy
-
I might even wrongbof my guess last week that this thing will be back to 40+ as it looks like it will even go down to 30+
️
-
Can not get a bid
-
WTF down 16 percent
-
It’s dropping like a rock!!
-
Use the weakness to accumulate MRNA
-
-
There is nothing shady or illegal. These executives have been selling stocks on weekly or bi- weekly basis. This is open information. See it for yourself:
-
Stop spinning ....shorts. Here is the interview with Moderna founder on planned stock sales and your conspiracy theories don’t have any ground.
https://www.cnbc.com/video/2020/05/20/moderna-founder-we-put-out-the-data-we-had-available.html
-
If I had worked my a** off to build a company or help it grow and had a chance to cash out for millions I would do it in a heartbeat. Especially if like me at my company the execs are all getting a TON more $MRNA stock every quarter and even more as raises. They know the weasels all over the market and on boards like this will find any reason or way to kill any stock. Throw in the government and political weasels and any stock can drop precipitously any day. I would cash in, too. If you thought about it, so would you.
-
-
-
-
-
Bavarian Nordic stock slides on Moderna mpox vaccine study (NASDAQ:MRNA)
news.google.com • -
Moderna updated COVID shot endorsed in EU (NASDAQ:MRNA)
news.google.com • -
Stephen Hoge Sells 318 Shares of Moderna, Inc. (NASDAQ:MRNA) Stock
news.google.com • -
Moderna Stock (MRNA) Nears a Support Level, Is It a Buy?
news.google.com • -
Smart Money Is Betting Big In MRNA Options
news.google.com • -
(MRNA) Trading Advice
news.google.com • -
Moderna CFO sells over $12k in company stock
news.google.com •